Patent details

Basic Information

Publication number:

EP1353916

PCT Application Number:

PCT/US/2001/049401

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP019943232

PCT Publication Number:

WO/2002/057259

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS

French Title of Invention:

COMPOSES DE PYRAZOLE UTILES EN TANT QU'INHIBITEURS DE PROTEINE KINASE

German Title of Invention:

PYRAZOLVERBINDUNGEN ALS PROTEIN- KINASEHEMMER

SPC Number:

Dates

Filing date:

19/12/2001

Grant date:

20/09/2006

EP Publication Date:

20/09/2006

PCT Publication Date:

25/07/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/10/2003

EP B1 Publication Date:

20/09/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

19/12/2012

Expiration date:

19/12/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/12/2001

 

 

Name:

VERTEX PHARMACEUTICALS INCORPORATED

Address:

130 Waverley Street, Cambridge, MA 01239-4212, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

15/11/2006

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

MILLER Andrew

Address:

United Kingdom (GB)

2

Name:

GOLEC Julian

Address:

United Kingdom (GB)

3

Name:

CHARRIER Jean-Damien, Vertex Pharmaceuticals Inc.

Address:

United Kingdom (GB)

4

Name:

KNEGTEL Ronald

Address:

United Kingdom (GB)

5

Name:

BEBBINGTON David

Address:

United Kingdom (GB)

Priority

1

Priority Number:

257887 P

Priority Date:

21/12/2000

Priority Country:

United States (US)

2

Priority Number:

286949 P

Priority Date:

27/04/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 403/12;

Filing date	Document type	Number of pages